Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Reduce Blood Loss in Transurethral Resection of Prostate
PACTR202407652050074Phase 3Completed
- Sponsor
- Ain Shams University Hospitals
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tranexamic acid in benign prostatic hyperplasia (BPH), sponsored by Ain Shams University Hospitals. Primary endpoints: Perioperative blood loss and Need for allogeneic blood transfusion. Started Sep 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on PACTR202407652050074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407652050074.